» Articles » PMID: 20166217

Osteoblastic Induction on Calcium Phosphate Cement-chitosan Constructs for Bone Tissue Engineering

Overview
Date 2010 Feb 19
PMID 20166217
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Calcium phosphate cement (CPC) is osteoconductive and moldable, and it can conform to complex cavity shapes and set in situ to form hydroxyapatite. Chitosan could increase the strength and toughness of CPC, but there has been no investigation on recombinant human bone morphogenic protein-2 (rhBMP-2) delivery via CPC-chitosan composite and its effect on osteogenic induction of cells. The objective of this research was to investigate the mechanical properties and osteoblastic induction of MC3T3-E1 cells cultured on CPC-containing chitosan and rhBMP-2. Cell viability for CPC with chitosan and rhBMP-2 was comparable with that of control CPC, whereas the CPC-chitosan composite was stronger and tougher than CPC control. After 14 days, osteoblastic induction was quantified by measuring alkaline phosphatase (ALP) activity. ALP (mean +/- SD; n = 6) of cells seeded on conventional CPC without rhBMP-2 was (143 +/- 19) (mM pNpp/min)/(mug DNA). The addition of chitosan resulted in an ALP of 161 +/- 27. Further addition of rhBMP-2 to the CPC-chitosan composite increased the ALP to 305 +/- 111 (p < 0.05). All ALP activity on CPC composites was significantly higher when compared with the 10.0 +/- 3.3 of tissue culture polystyrene (p < 0.05). Flexural strength of CPC containing 15% (mass fraction) chitosan was 19.8 +/- 1.4 MPa, which is more than double the 8.0 +/- 1.4 MPa of conventional CPC (p < 0.05). The addition of chitosan to CPC increased the fracture toughness from 0.18 +/- 0.01 MPa.m(1/2) to 0.23 +/- 0.02 MPa.m(1/2) (p < 0.05). The relatively high strength, self-hardening CPC-chitosan composite scaffold is promising as a moderate load-bearing matrix for bone repair, with potential to serve as an injectable delivery vehicle for osteoinductive growth factors to promote osteoblastic induction and bone regeneration. (c) 2010 Wiley Periodicals, Inc. J Biomed Mater Res, 2010.

Citing Articles

Stability, challenges, and prospects of chitosan for the delivery of anticancer drugs and tissue regenerative growth factors.

Rahman M, Mondal M Heliyon. 2024; 10(21):e39879.

PMID: 39583848 PMC: 11582409. DOI: 10.1016/j.heliyon.2024.e39879.


Effect of chitosan/inorganic nanomaterial scaffolds on bone regeneration and related influencing factors in animal models: A systematic review.

Guo A, Zheng Y, Zhong Y, Mo S, Fang S Front Bioeng Biotechnol. 2022; 10:986212.

PMID: 36394038 PMC: 9643585. DOI: 10.3389/fbioe.2022.986212.


Human periodontal ligament stem cells on calcium phosphate scaffold delivering platelet lysate to enhance bone regeneration.

Zhao Z, Liu J, Weir M, Zhang N, Zhang L, Xie X RSC Adv. 2022; 9(70):41161-41172.

PMID: 35540034 PMC: 9076431. DOI: 10.1039/c9ra08336g.


Injectable Biomaterials for Dental Tissue Regeneration.

Haugen H, Basu P, Sukul M, Mano J, Reseland J Int J Mol Sci. 2020; 21(10).

PMID: 32414077 PMC: 7279163. DOI: 10.3390/ijms21103442.


Combined construction of injectable tissue-engineered bone with CPC and BMMSCs and its study of repair effect on rabbit bone defect model.

Li G, Shen W, Zhao L, Wang T, Pan Z, Sheng S J Musculoskelet Neuronal Interact. 2020; 20(1):142-148.

PMID: 32131379 PMC: 7104586.


References
1.
Huse R, Ruhe P, Wolke J, Jansen J . The use of porous calcium phosphate scaffolds with transforming growth factor beta 1 as an onlay bone graft substitute. Clin Oral Implants Res. 2004; 15(6):741-9. DOI: 10.1111/j.1600-0501.2004.01068.x. View

2.
Tsiridis E, Bhalla A, Ali Z, Gurav N, Heliotis M, Deb S . Enhancing the osteoinductive properties of hydroxyapatite by the addition of human mesenchymal stem cells, and recombinant human osteogenic protein-1 (BMP-7) in vitro. Injury. 2006; 37 Suppl 3:S25-32. DOI: 10.1016/j.injury.2006.08.021. View

3.
Ruhe P, Hedberg E, Padron N, Spauwen P, Jansen J, Mikos A . rhBMP-2 release from injectable poly(DL-lactic-co-glycolic acid)/calcium-phosphate cement composites. J Bone Joint Surg Am. 2003; 85-A Suppl 3:75-81. DOI: 10.2106/00004623-200300003-00013. View

4.
Xu H, Carey L, Simon Jr C . Premixed macroporous calcium phosphate cement scaffold. J Mater Sci Mater Med. 2007; 18(7):1345-53. PMC: 2645046. DOI: 10.1007/s10856-007-0146-x. View

5.
Brandoff J, Silber J, Vaccaro A . Contemporary alternatives to synthetic bone grafts for spine surgery. Am J Orthop (Belle Mead NJ). 2008; 37(8):410-4. View